Skip to main content

Global Advanced Balloon Catheter Market Witnessing A CAGR of 6.25% During the Forecast Period 2021-2030

 According to a new market intelligence report by BIS Research titled ‘Global Advanced Balloon Catheter Market − Analysis and Forecast, 2021-20230’, In the pre-COVID-19 scenario the global advanced balloon catheter market was valued at $2,523.9 million in 2019 and was anticipated to reach up to $4405.3 million in 2030 witnessing a CAGR of 6.25% during the forecast period 2021-2030.


BIS Research Report: https://bisresearch.com/industry-report/advanced-balloon-catheter-market.html


The global advanced balloon catheter market is driven by various factors, such as the increasing prevalence of CVDs and PAD, rising demand for minimally invasive procedures, advancements in balloon catheters, and the favorable reimbursement landscape in developed economies. The driving factors are anticipated to propel the growth of the market during the forecast 2021-2030.


The global advanced balloon catheter industry comprises various stakeholders, namely, balloon catheter manufacturers, distributors, and regulators. The stakeholders are responsible for the manufacturing, distribution, approval, and regulation of the balloon catheters available in the market.


Request for Sample Report:  https://bisresearch.com/requestsample?id=1012&type=download


The global advanced balloon catheter market is consolidated in nature with companies such as Boston Scientific Corporation, Terumo Corporation, Medtronic plc, Abbott Laboratories, B.Braun Melsungen AG, Koninklijke Philips N.V., Becton, Dickinson and Company (BD), holding 65.50% share in the overall market cumulatively.


Key Questions Answered in this Report:


•    How has the COVID-19 pandemic impacted the global advanced balloon catheter market?


•    What is the adoption rate of the balloon catheters in peripheral artery disease (PAD) and coronary artery disease (CAD) across various regions?


•    What is the reimbursement landscape for the balloon catheters across various regions?


•    How does the regulatory landscape for the balloon catheters impact the overall global advanced balloon catheter market?


•    Who are the key players in the global advanced balloon catheters and their respective market share?

About BIS Research:

BIS Research is a global B2B market intelligence and advisory firm focusing on those emerging technological trends which are likely to disrupt the dynamics of the market.

With over 150 market research reports published annually, BIS Research focuses on high technology verticals such as 3D Printing, Advanced Materials and Chemicals, Aerospace and Defense, Automotive, Healthcare, Electronics and Semiconductors, Robotics and UAV, and other emerging technologies.

Our in-depth market intelligence reports focus on the market estimations, technology analysis, emerging high-growth applications, deeply segmented granular country-level market data, and other important market parameters useful in the strategic decision-making for senior management.

What distinguishes BIS Research from the rest of the players is that we don’t simply provide data but also complement it with valuable insights and actionable inputs for the success of our clients.










 

Labels:

Comments

Post a Comment

Popular posts from this blog

Microbiome Therapeutics Market Growth, Segmentation, Opportunity and Forecast to 2032

  Global microbiome therapeutics market is expected to grow further in the coming years due to the continuous increase in awareness and need for better and safer treatment alternatives and the dominance of gastrointestinal (GI) and infectious diseases segment can be attributed to the existing dominance of microbiome therapeutics available for a variety of indications ranging from diarrhea and gut dysbiosis to skin disorders, cancer indications among others. The global microbiome therapeutics market which accounted for $306.3 million in 2021 is expected to reach $3,204 million by 2032, reporting a CAGR of 24.95% during the forecast period 2022-2032. The existing   microbiome therapeutics market    is favored by multiple factors, including the rising geriatric populations coupled with the increasing adoption of inorganic growth strategies by key players in the market. Impact of COVID-19 There were numerous consequences due to the COVID-19 pandemic, especially...
Post a Comment
Read more

Lung Cancer Genomic Testing Market Industry Structure, Development, Demographics, Demands, Main Players, Innovative Technologies, and Opportunities Till 2031

  The shift of healthcare systems toward precision diagnostic and precision medicine will drive the adoption of lung cancer genomic testing facilitating informed treatment decision making and improving healthcare outcomes. Increasing recommendations by the international oncology societies for the use of genomic testing for lung cancer diagnosis provides major opportunities in the global lung cancer genomic testing market. The  lung cancer genomic testing medicine market  was valued at $1,262.0 million in 2020 and is expected to reach $3,279.8 million by 2031, growing at a CAGR of 8.97% during the forecast period 2021-2031. The growth in the global lung cancer genomic testing market is expected to be driven by increasing awareness and adoption of the lung cancer genomic testing market, recent launches of novel lung cancer genomic testing, and the expanding research in the field of lung cancer with an emphasis on pharmacogenomics and development of companion diagnostics. Im...
Post a Comment
Read more

Ligase Market Opportunities, Strategies, Share, Segmentation, In-depth Analysis 2032

  The global ligase market is progressing rapidly with a significant increase in the research and development activities pertaining to a wide range of ligase product for disease detection, accentuating their criticality in healthcare. Ligase enzyme has a critical role in the molecular diagnostics approach, as it ensures the safe and effective application of targeted therapeutics. Most of the players in the global ligase market offer products encompassing the ligation kits and enzymes. The global  ligase market  is projected to reach $651.4 million by 2032 from $371.2 million in 2021, at a CAGR of 5.29% during the forecast period 2022-2032. The growth in the global ligase market is expected to be driven by factors such as the increasing prevalence of infectious and genetic diseases on a global level, rising awareness of enzyme based diagnostic testing and significant number of funding for executing research and development.   Impact Several techniques are employed in ...
Post a Comment
Read more